About Us

Our Partners & Investors

Boston Scientific and Functional Neuromodulation entered into a strategic investment partnership in 2016 to further develop DBS of the fornix for mild Alzheimer's disease patients.


Functional Neuromodulation recently closed a $10.4 million round of financing with Genesys Capital, one of the largest Canadian-based venture capital firms exclusively focused on the life sciences industry.


CAUTION — Investigational device. Limited by Federal law to investigational use.

Functional Neuromodulation, Ltd.
200 South Sixth Street Suite 3400 | Minneapolis, MN 55402 | info@fxneuromod.com | 1-866-296-4040
© Functional Neuromodulation Ltd. All rights reserved.